Marker Therapeutics (MRKR) EBIT (QoQ) (2010 - 2026)
Marker Therapeutics (MRKR) EBIT (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | Marker Therapeutics | 26.46 Mn | 14.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -116.16% |
| Dec 31, 2025 | 11.83% |
| Sep 30, 2025 | 49.85% |
| Jun 30, 2025 | 14.05% |
| Mar 31, 2025 | -28.39% |
| Dec 31, 2024 | -60.90% |
| Sep 30, 2024 | -3.98% |
| Jun 30, 2024 | 9.45% |
| Mar 31, 2024 | 13.23% |
| Dec 31, 2023 | 8.20% |
| Sep 30, 2023 | 22.59% |
| Jun 30, 2023 | 4.07% |
| Mar 31, 2023 | -41.82% |
| Dec 31, 2022 | 47.85% |
| Sep 30, 2022 | -10.59% |
| Jun 30, 2022 | 46.21% |
| Mar 31, 2022 | -0.31% |
| Dec 31, 2021 | 2.59% |
| Sep 30, 2021 | 8.12% |
| Jun 30, 2021 | -24.24% |